Bladder cancer clinical trials

Explore recruiting bladder cancer clinical trials.

Recruiting bladder cancer studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Bladder cancer trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Randomized Phase II Trial assessing Trimodality Therapy With or Without Adjuvant Durvalumab (MEDI4736) to Treat Patients with Muscle-Invasive Bladder Cancer

Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

A Randomized Phase III Study to Investigate the Efficacy and Safety of Alpha1H as a Neoadjuvant Therapy in Participants with Low- to Intermediate-Risk/Low-Grade Papillary Non-Muscle Invasive Bladder Cancer

Czechia

Therapeutic confirmatory (Phase III) EU CTIS Study details

Intravesical Mistletoe Extract in Superficial Bladder Cancer: A Phase III Efficacy Study

Germany

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Randomized Placebo controlled Phase I/II Study Evaluating the Safety and Efficacy of Alpha1H in adult patients with non-muscle invasive bladder cancer awaiting transurethral surgery

Czechia

Phase I and Phase II (Integrated)- Other EU CTIS Study details

C5701002/SGN22E-002 - A study of enfortumab vedotin (ASG-22CE) as monotherapy or in combination with other anticancer therapies for the treatment of urothelial cancer

France

Therapeutic exploratory (Phase II) EU CTIS Study details

COBRA - Chemoablation for Low Grade Bladder Cancer: A single arm, prospective, open-label, investigator-initiated Phase 2 study

Austria

Therapeutic exploratory (Phase II) EU CTIS Study details

Bladder cancer trials by city

Bladder cancer in Toronto Bladder cancer in Vancouver Bladder cancer in Montreal Bladder cancer in Calgary Bladder cancer in Edmonton Bladder cancer in Ottawa Bladder cancer in Winnipeg Bladder cancer in Quebec City Bladder cancer in Hamilton Bladder cancer in Kitchener Bladder cancer in London Bladder cancer in Halifax Bladder cancer in New York Bladder cancer in Los Angeles Bladder cancer in Chicago Bladder cancer in Houston

Other conditions

Enlarged prostate (BPH) Breast cancer Prostate cancer Lung cancer Non-small cell lung cancer Colorectal cancer Pancreatic cancer Ovarian cancer Melanoma Leukemia Lymphoma Multiple myeloma Kidney cancer Liver cancer Glioblastoma Head and neck cancer Cervical cancer Endometrial cancer Gastric cancer Age-related macular degeneration Diabetic retinopathy Glaucoma Dry eye disease HIV